{"id":5612,"date":"2025-02-07T14:25:53","date_gmt":"2025-02-07T14:25:53","guid":{"rendered":"https:\/\/itbusinesstoday.com\/?p=5612"},"modified":"2025-05-06T09:24:36","modified_gmt":"2025-05-06T09:24:36","slug":"tensegrity-pharma-reevaluating-drug-candidates-from-unique-perspective-raises-additional-150-million-yen-in-seed-round","status":"publish","type":"post","link":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/tensegrity-pharma-reevaluating-drug-candidates-from-unique-perspective-raises-additional-150-million-yen-in-seed-round\/","title":{"rendered":"\u72ec\u81ea\u306e\u8996\u70b9\u3067\u533b\u85ac\u54c1\u5019\u88dc\u3092\u518d\u8a55\u4fa1\u3059\u308b\u30c6\u30f3\u30bb\u30b0\u30ea\u30c6\u30a3\u30fb\u30d5\u30a1\u30fc\u30de\u304c\u30b7\u30fc\u30c9\u30e9\u30a6\u30f3\u30c9\u30671\u51045000\u4e07\u5186\u3092\u8ffd\u52a0\u8abf\u9054"},"content":{"rendered":"<p>\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u65b0\u8208\u4f01\u696d <a href=\"https:\/\/jp.tensegritypharma.com\/\">\u30c6\u30f3\u30bb\u30b0\u30ea\u30c6\u30a3\u30fb\u30d5\u30a1\u30fc\u30de<\/a> \u306f31\u65e5\u30011\u51045,000\u4e07\u5186\u306e\u30b7\u30fc\u30c9\u8cc7\u91d1\u8abf\u9054\u3092\u767a\u8868\u3002\u3053\u306e\u30e9\u30a6\u30f3\u30c9\u306b\u306f\u4e09\u83f1UFJ\u30ad\u30e3\u30d4\u30bf\u30eb\u3082\u53c2\u52a0\u3057\u3066\u304a\u308a\u30012024\u5e7411\u6708\u306e\u30cb\u30e5\u30fc\u30c8\u30f3\u30d0\u30a4\u30aa\u30ad\u30e3\u30d4\u30bf\u30eb\u304b\u3089\u306e5\u5104\u5186\u3068\u5408\u308f\u305b\u3066\u3001\u30b7\u30fc\u30c9\u30e9\u30a6\u30f3\u30c9\u306e\u7d2f\u8a08\u8cc7\u91d1\u8abf\u9054\u984d\u306f6\u51045,000\u4e07\u5186\u3068\u306a\u308a\u307e\u3057\u305f\u3002<\/p>\n<p>2023\u5e743\u6708\u306b\u8a2d\u7acb\u3055\u308c\u305f\u540c\u793e\u306f\u3001\u6226\u7565\u7684\u306b\u958b\u767a\u304c\u4e2d\u6b62\u3055\u308c\u305f\u65b0\u85ac\u5019\u88dc\u3092\u8a55\u4fa1\u30fb\u56de\u53ce\u3059\u308b\u30d3\u30b8\u30cd\u30b9\u30e2\u30c7\u30eb\u3092\u5c55\u958b\u3057\u3066\u304a\u308a\u3001\u72ec\u81ea\u306e\u5275\u85ac\u8996\u70b9\u3092\u6d3b\u304b\u3057\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u63a2\u7d22\u7684\u81e8\u5e8a\u958b\u767a\u8a66\u9a13\u3092\u901a\u3058\u3066\u4fa1\u5024\u306e\u6700\u5927\u5316\u3092\u56f3\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u73fe\u5728\u958b\u767a\u4e2d\u306e TSP-101 \u306f\u3001\u30a2\u30b9\u30c6\u30e9\u30b9\u88fd\u85ac\u304b\u3089\u53d7\u3051\u7d99\u3044\u3060\u524d\u81e8\u5e8a\u958b\u767a\u54c1\u3067\u3042\u308a\u3001\u60aa\u6db2\u8cea\u6cbb\u7642\u85ac\u3068\u3057\u3066\u306e \u958b\u767a\u3092\u76ee\u6307\u3057\u3066\u3044\u307e\u3059\u3002\u60aa\u6db2\u8cea\u306f\u3001\u304c\u3093\u3001\u5fc3\u81d3\u75c5\u3001\u611f\u67d3\u75c7\u306a\u3069\u306e\u6162\u6027\u75be\u60a3\u306b\u4f34\u3046\u4f53\u91cd\u6e1b\u5c11\u3092\u7279\u5fb4\u3068\u3059\u308b\u75c7\u5019\u7fa4\u3067\u3059\u3002\u305d\u306e\u75c5\u614b\u306f\u5b8c\u5168\u306b\u306f\u89e3\u660e\u3055\u308c\u3066\u304a\u3089\u305a\u3001\u7d71\u4e00\u7684\u306a\u6cbb\u7642\u6cd5\u3084\u627f\u8a8d\u3055\u308c\u305f\u6cbb\u7642\u85ac\u306f\u3042\u308a\u307e\u305b\u3093\u3002<\/p>\n<h4><strong>\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a <a class=\"p-url\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/enyu-pharma-raises-400m-yen-in-seed-funding-for-glycopeptide-antibody-drugs\/\" rel=\"bookmark\">\u30a8\u30f3\u30e6\u30d5\u30a1\u30fc\u30de\u3001\u7cd6\u30da\u30d7\u30c1\u30c9\u6297\u4f53\u533b\u85ac\u54c1\u30674\u5104\u5186\u306e\u30b7\u30fc\u30c9\u8cc7\u91d1\u3092\u8abf\u9054<\/a><\/strong><\/h4>\n<p>\u7279\u306b\u3001\u304c\u3093\u306b\u95a2\u9023\u3057\u305f\u60aa\u6db2\u8cea\u306f\u3001\u901a\u5e38\u306e\u6804\u990a\u88dc\u7d66\u3067\u306f\u56de\u5fa9\u304c\u56f0\u96e3\u306a\u591a\u56e0\u5b50\u75be\u60a3\u3067\u3042\u308a\u3001\u6301\u7d9a\u7684\u306a\u9aa8\u683c\u7b4b\u306e\u6e1b\u5c11\u304c\u4e3b\u306a\u7279\u5fb4\u3067\u3059\u3002\u540c\u793e\u306b\u3088\u308b\u3068\u3001\u3053\u306e\u5408\u4f75\u75c7\u306f\u304c\u3093\u60a3\u8005\u306e\u7d0480%\u306b\u73fe\u308c\u3001\u4f53\u91cd\u6e1b\u5c11\u3084\u98df\u6b32\u4e0d\u632f\u3092\u5f15\u304d\u8d77\u3053\u3057\u3001\u5316\u5b66\u7642\u6cd5\u306e\u52b9\u679c\u306e\u4f4e\u4e0b\u3001\u526f\u4f5c\u7528\u306e\u5897\u52a0\u3001\u6cbb\u7642\u306e\u4e2d\u65ad\u306a\u3069\u306e\u554f\u984c\u306b\u3064\u306a\u304c\u308a\u307e\u3059\u3002<\/p>\n<p>TSP-101\u306f\u3001\u60aa\u6db2\u8cea\u306e\u767a\u751f\u983b\u5ea6\u304c\u9ad8\u3044\u69d8\u3005\u306a\u764c\u3067\u904e\u5270\u767a\u73fe\u3057\u3066\u3044\u308b\u7279\u5b9a\u56e0\u5b50\u306e\u30b7\u30b0\u30ca\u30eb\u3092\u906e\u65ad\u3057\u3001\u764c\u7531\u6765\u306e\u5168\u8eab\u6027\u708e\u75c7\u53cd\u5fdc\u3092\u6291\u5236\u3059\u308b\u3053\u3068\u306b\u3088\u308b\u6297\u60aa\u6db2\u8cea\u4f5c\u7528\u3068\u3001\u764c\u5fae\u5c0f\u74b0\u5883\u306e\u6539\u5584\u306b\u3088\u308b\u6297\u764c\u4f5c\u7528\u304c\u671f\u5f85\u3055\u308c\u307e\u3059\u3002\u5f53\u793e\u306f\u3001\u4eca\u56de\u306e\u8cc7\u91d1\u8abf\u9054\u306b\u3088\u308a\u3001TSP-101\u306e\u81e8\u5e8a\u7b2c1\/2\u76f8\u8a66\u9a13\u3078\u306e\u65e9\u671f\u79fb\u884c\u3068\u3001\u81e8\u5e8aPOC\uff08Proof of Concept\uff1a\u5275\u85ac\u6982\u5ff5\u306e\u691c\u8a3c\uff09\u306e\u65e9\u671f\u53d6\u5f97\u3092\u76ee\u6307\u3057\u307e\u3059\u3002<\/p>\n<p><strong>\u30bd\u30fc\u30b9 <a href=\"https:\/\/thebridge.jp\/en\/2025\/02\/tensegrity-pharma-raises-an-additional-150-million-yen-in-seed-round\">\u30d6\u30ea\u30c3\u30b8<\/a><\/strong><\/p>","protected":false},"excerpt":{"rendered":"<p>Biotech startup Tensegrity Pharma announced on the 31st raising 150 million yen in seed funding. This round saw participation from Mitsubishi UFJ Capital, bringing their cumulative seed round funding to 650 million yen, including 500 million yen from Newton Bio Capital in November 2024. Founded in March 2023, the company operates a business model of evaluating and recovering drug candidates strategically discontinued from development, using their unique drug discovery perspective to maximize value through global exploratory clinical development trials. TSP-101, currently under development, is a preclinical development product inherited from Astellas Pharma, targeted for development as a cachexia treatment. Cachexia is a syndrome characterized by weight loss associated with chronic [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":5613,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[208,89,198,211,237,206],"tags":[150,641,917,424,918,919,916],"ppma_author":[205],"class_list":{"0":"post-5612","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-apac","8":"category-health-tech","9":"category-investments","10":"category-japan","11":"category-news","12":"category-regional","13":"tag-biotech","14":"tag-investment","15":"tag-mitsubishi-ufj-capital","16":"tag-pharma","17":"tag-seed-funding","18":"tag-tensegrity-pharma","19":"tag-tsp-101"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tensegrity Pharma Raises \u00a5150M in Seed Round<\/title>\n<meta name=\"description\" content=\"Tensegrity Pharma a Biotech startup announced on the 31st raising 150 million yen in seed funding from Mitsubishi UFJ Capital.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/tensegrity-pharma-reevaluating-drug-candidates-from-unique-perspective-raises-additional-150-million-yen-in-seed-round\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tensegrity Pharma Raises \u00a5150M in Seed Round\" \/>\n<meta property=\"og:description\" content=\"Tensegrity Pharma a Biotech startup announced on the 31st raising 150 million yen in seed funding from Mitsubishi UFJ Capital.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/tensegrity-pharma-reevaluating-drug-candidates-from-unique-perspective-raises-additional-150-million-yen-in-seed-round\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-07T14:25:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-06T09:24:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/02\/Tensegrity-Pharma_-Reevaluating-Drug-Candidates-from-Unique-Perspective_-Raises-Additional-150-Million-Yen-in-Seed-Round.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NewsDesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"NewsDesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30c6\u30f3\u30bb\u30b0\u30ea\u30c6\u30a3\u30fb\u30d5\u30a1\u30fc\u30de\u3001\u30b7\u30fc\u30c9\u30fb\u30e9\u30a6\u30f3\u30c9\u30671\u51045000\u4e07\u5186\u3092\u8abf\u9054","description":"\u30d0\u30a4\u30aa\u30d9\u30f3\u30c1\u30e3\u30fc\u306e\u30c6\u30f3\u30bb\u30b0\u30ea\u30c6\u30a3\u30fb\u30d5\u30a1\u30fc\u30de\u306f31\u65e5\u3001\u4e09\u83f1UFJ\u30ad\u30e3\u30d4\u30bf\u30eb\u304b\u30891\u51045000\u4e07\u5186\u306e\u30b7\u30fc\u30c9\u8cc7\u91d1\u3092\u8abf\u9054\u3057\u305f\u3068\u767a\u8868\u3057\u307e\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/tensegrity-pharma-reevaluating-drug-candidates-from-unique-perspective-raises-additional-150-million-yen-in-seed-round\/","og_locale":"ja_JP","og_type":"article","og_title":"Tensegrity Pharma Raises \u00a5150M in Seed Round","og_description":"Tensegrity Pharma a Biotech startup announced on the 31st raising 150 million yen in seed funding from Mitsubishi UFJ Capital.","og_url":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/tensegrity-pharma-reevaluating-drug-candidates-from-unique-perspective-raises-additional-150-million-yen-in-seed-round\/","og_site_name":"itbusinesstoday","article_published_time":"2025-02-07T14:25:53+00:00","article_modified_time":"2025-05-06T09:24:36+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/02\/Tensegrity-Pharma_-Reevaluating-Drug-Candidates-from-Unique-Perspective_-Raises-Additional-150-Million-Yen-in-Seed-Round.webp","type":"image\/webp"}],"author":"NewsDesk","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"NewsDesk","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/health-tech\/tensegrity-pharma-reevaluating-drug-candidates-from-unique-perspective-raises-additional-150-million-yen-in-seed-round\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/tensegrity-pharma-reevaluating-drug-candidates-from-unique-perspective-raises-additional-150-million-yen-in-seed-round\/"},"author":{"name":"NewsDesk","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/d58d81f55e8acd257ab63d49fb4ea812"},"headline":"Tensegrity Pharma, Reevaluating Drug Candidates from Unique Perspective, Raises Additional 150 Million Yen in Seed Round","datePublished":"2025-02-07T14:25:53+00:00","dateModified":"2025-05-06T09:24:36+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/tensegrity-pharma-reevaluating-drug-candidates-from-unique-perspective-raises-additional-150-million-yen-in-seed-round\/"},"wordCount":278,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/tensegrity-pharma-reevaluating-drug-candidates-from-unique-perspective-raises-additional-150-million-yen-in-seed-round\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/02\/Tensegrity-Pharma_-Reevaluating-Drug-Candidates-from-Unique-Perspective_-Raises-Additional-150-Million-Yen-in-Seed-Round.webp","keywords":["Biotech","Investment","Mitsubishi UFJ Capital","Pharma","seed funding","Tensegrity Pharma","TSP-101"],"articleSection":["APAC","Health Tech","Investments","Japan","News","Regional"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/health-tech\/tensegrity-pharma-reevaluating-drug-candidates-from-unique-perspective-raises-additional-150-million-yen-in-seed-round\/","url":"https:\/\/itbusinesstoday.com\/health-tech\/tensegrity-pharma-reevaluating-drug-candidates-from-unique-perspective-raises-additional-150-million-yen-in-seed-round\/","name":"\u30c6\u30f3\u30bb\u30b0\u30ea\u30c6\u30a3\u30fb\u30d5\u30a1\u30fc\u30de\u3001\u30b7\u30fc\u30c9\u30fb\u30e9\u30a6\u30f3\u30c9\u30671\u51045000\u4e07\u5186\u3092\u8abf\u9054","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/tensegrity-pharma-reevaluating-drug-candidates-from-unique-perspective-raises-additional-150-million-yen-in-seed-round\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/tensegrity-pharma-reevaluating-drug-candidates-from-unique-perspective-raises-additional-150-million-yen-in-seed-round\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/02\/Tensegrity-Pharma_-Reevaluating-Drug-Candidates-from-Unique-Perspective_-Raises-Additional-150-Million-Yen-in-Seed-Round.webp","datePublished":"2025-02-07T14:25:53+00:00","dateModified":"2025-05-06T09:24:36+00:00","description":"\u30d0\u30a4\u30aa\u30d9\u30f3\u30c1\u30e3\u30fc\u306e\u30c6\u30f3\u30bb\u30b0\u30ea\u30c6\u30a3\u30fb\u30d5\u30a1\u30fc\u30de\u306f31\u65e5\u3001\u4e09\u83f1UFJ\u30ad\u30e3\u30d4\u30bf\u30eb\u304b\u30891\u51045000\u4e07\u5186\u306e\u30b7\u30fc\u30c9\u8cc7\u91d1\u3092\u8abf\u9054\u3057\u305f\u3068\u767a\u8868\u3057\u307e\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/tensegrity-pharma-reevaluating-drug-candidates-from-unique-perspective-raises-additional-150-million-yen-in-seed-round\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/health-tech\/tensegrity-pharma-reevaluating-drug-candidates-from-unique-perspective-raises-additional-150-million-yen-in-seed-round\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/health-tech\/tensegrity-pharma-reevaluating-drug-candidates-from-unique-perspective-raises-additional-150-million-yen-in-seed-round\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/02\/Tensegrity-Pharma_-Reevaluating-Drug-Candidates-from-Unique-Perspective_-Raises-Additional-150-Million-Yen-in-Seed-Round.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/02\/Tensegrity-Pharma_-Reevaluating-Drug-Candidates-from-Unique-Perspective_-Raises-Additional-150-Million-Yen-in-Seed-Round.webp","width":1200,"height":800,"caption":"Tensegrity-Pharma"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/health-tech\/tensegrity-pharma-reevaluating-drug-candidates-from-unique-perspective-raises-additional-150-million-yen-in-seed-round\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"Tensegrity Pharma, Reevaluating Drug Candidates from Unique Perspective, Raises Additional 150 Million Yen in Seed Round"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/d58d81f55e8acd257ab63d49fb4ea812","name":"\u30cb\u30e5\u30fc\u30b9\u30c7\u30b9\u30af","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png74f313ad3d6fa27a1eee85c30be63d03","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","caption":"NewsDesk"},"sameAs":["https:\/\/itbusinesstoday.com"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/newsdesk\/"}]}},"authors":[{"term_id":205,"user_id":4,"is_guest":0,"slug":"newsdesk","display_name":"NewsDesk","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png"},"0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/5612","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=5612"}],"version-history":[{"count":2,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/5612\/revisions"}],"predecessor-version":[{"id":10897,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/5612\/revisions\/10897"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/5613"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=5612"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=5612"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=5612"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=5612"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}